

The global Virus-like Particle (VLP) Service market size is predicted to grow from US$ 845 million in 2025 to US$ 1435 million in 2031; it is expected to grow at a CAGR of 9.2% from 2025 to 2031.
Virus-like Particle (VLP) Service company offer both VLP production services and various VLP products for multiple applications, such as delivery system, vaccine development, and membrane protein expression.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The “Virus-like Particle (VLP) Service Industry Forecast” looks at past sales and reviews total world Virus-like Particle (VLP) Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Virus-like Particle (VLP) Service sales for 2025 through 2031. With Virus-like Particle (VLP) Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Virus-like Particle (VLP) Service industry.
This Insight Report provides a comprehensive analysis of the global Virus-like Particle (VLP) Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Virus-like Particle (VLP) Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Virus-like Particle (VLP) Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Virus-like Particle (VLP) Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Virus-like Particle (VLP) Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Virus-like Particle (VLP) Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
E. coli
Yeast
Insect Cells
Others
Segmentation by Application:
Drug Research
Drug Target Recognition
Vaccine Development
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Creative Biostructure
Creative Diagnostics
Creative Biolabs
Creative Biogene
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Virus-like Particle (VLP) Service Market Size (2020-2031)
2.1.2 Virus-like Particle (VLP) Service Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Virus-like Particle (VLP) Service by Country/Region (2020, 2024 & 2031)
2.2 Virus-like Particle (VLP) Service Segment by Type
2.2.1 E. coli
2.2.2 Yeast
2.2.3 Insect Cells
2.2.4 Others
2.3 Virus-like Particle (VLP) Service Market Size by Type
2.3.1 Virus-like Particle (VLP) Service Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Virus-like Particle (VLP) Service Market Size Market Share by Type (2020-2025)
2.4 Virus-like Particle (VLP) Service Segment by Application
2.4.1 Drug Research
2.4.2 Drug Target Recognition
2.4.3 Vaccine Development
2.4.4 Others
2.5 Virus-like Particle (VLP) Service Market Size by Application
2.5.1 Virus-like Particle (VLP) Service Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Virus-like Particle (VLP) Service Market Size Market Share by Application (2020-2025)
3 Virus-like Particle (VLP) Service Market Size by Player
3.1 Virus-like Particle (VLP) Service Market Size Market Share by Player
3.1.1 Global Virus-like Particle (VLP) Service Revenue by Player (2020-2025)
3.1.2 Global Virus-like Particle (VLP) Service Revenue Market Share by Player (2020-2025)
3.2 Global Virus-like Particle (VLP) Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Virus-like Particle (VLP) Service by Region
4.1 Virus-like Particle (VLP) Service Market Size by Region (2020-2025)
4.2 Global Virus-like Particle (VLP) Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Virus-like Particle (VLP) Service Market Size Growth (2020-2025)
4.4 APAC Virus-like Particle (VLP) Service Market Size Growth (2020-2025)
4.5 Europe Virus-like Particle (VLP) Service Market Size Growth (2020-2025)
4.6 Middle East & Africa Virus-like Particle (VLP) Service Market Size Growth (2020-2025)
5 Americas
5.1 Americas Virus-like Particle (VLP) Service Market Size by Country (2020-2025)
5.2 Americas Virus-like Particle (VLP) Service Market Size by Type (2020-2025)
5.3 Americas Virus-like Particle (VLP) Service Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Virus-like Particle (VLP) Service Market Size by Region (2020-2025)
6.2 APAC Virus-like Particle (VLP) Service Market Size by Type (2020-2025)
6.3 APAC Virus-like Particle (VLP) Service Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Virus-like Particle (VLP) Service Market Size by Country (2020-2025)
7.2 Europe Virus-like Particle (VLP) Service Market Size by Type (2020-2025)
7.3 Europe Virus-like Particle (VLP) Service Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Virus-like Particle (VLP) Service by Region (2020-2025)
8.2 Middle East & Africa Virus-like Particle (VLP) Service Market Size by Type (2020-2025)
8.3 Middle East & Africa Virus-like Particle (VLP) Service Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Virus-like Particle (VLP) Service Market Forecast
10.1 Global Virus-like Particle (VLP) Service Forecast by Region (2026-2031)
10.1.1 Global Virus-like Particle (VLP) Service Forecast by Region (2026-2031)
10.1.2 Americas Virus-like Particle (VLP) Service Forecast
10.1.3 APAC Virus-like Particle (VLP) Service Forecast
10.1.4 Europe Virus-like Particle (VLP) Service Forecast
10.1.5 Middle East & Africa Virus-like Particle (VLP) Service Forecast
10.2 Americas Virus-like Particle (VLP) Service Forecast by Country (2026-2031)
10.2.1 United States Market Virus-like Particle (VLP) Service Forecast
10.2.2 Canada Market Virus-like Particle (VLP) Service Forecast
10.2.3 Mexico Market Virus-like Particle (VLP) Service Forecast
10.2.4 Brazil Market Virus-like Particle (VLP) Service Forecast
10.3 APAC Virus-like Particle (VLP) Service Forecast by Region (2026-2031)
10.3.1 China Virus-like Particle (VLP) Service Market Forecast
10.3.2 Japan Market Virus-like Particle (VLP) Service Forecast
10.3.3 Korea Market Virus-like Particle (VLP) Service Forecast
10.3.4 Southeast Asia Market Virus-like Particle (VLP) Service Forecast
10.3.5 India Market Virus-like Particle (VLP) Service Forecast
10.3.6 Australia Market Virus-like Particle (VLP) Service Forecast
10.4 Europe Virus-like Particle (VLP) Service Forecast by Country (2026-2031)
10.4.1 Germany Market Virus-like Particle (VLP) Service Forecast
10.4.2 France Market Virus-like Particle (VLP) Service Forecast
10.4.3 UK Market Virus-like Particle (VLP) Service Forecast
10.4.4 Italy Market Virus-like Particle (VLP) Service Forecast
10.4.5 Russia Market Virus-like Particle (VLP) Service Forecast
10.5 Middle East & Africa Virus-like Particle (VLP) Service Forecast by Region (2026-2031)
10.5.1 Egypt Market Virus-like Particle (VLP) Service Forecast
10.5.2 South Africa Market Virus-like Particle (VLP) Service Forecast
10.5.3 Israel Market Virus-like Particle (VLP) Service Forecast
10.5.4 Turkey Market Virus-like Particle (VLP) Service Forecast
10.6 Global Virus-like Particle (VLP) Service Forecast by Type (2026-2031)
10.7 Global Virus-like Particle (VLP) Service Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Virus-like Particle (VLP) Service Forecast
11 Key Players Analysis
11.1 Creative Biostructure
11.1.1 Creative Biostructure Company Information
11.1.2 Creative Biostructure Virus-like Particle (VLP) Service Product Offered
11.1.3 Creative Biostructure Virus-like Particle (VLP) Service Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Creative Biostructure Main Business Overview
11.1.5 Creative Biostructure Latest Developments
11.2 Creative Diagnostics
11.2.1 Creative Diagnostics Company Information
11.2.2 Creative Diagnostics Virus-like Particle (VLP) Service Product Offered
11.2.3 Creative Diagnostics Virus-like Particle (VLP) Service Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Creative Diagnostics Main Business Overview
11.2.5 Creative Diagnostics Latest Developments
11.3 Creative Biolabs
11.3.1 Creative Biolabs Company Information
11.3.2 Creative Biolabs Virus-like Particle (VLP) Service Product Offered
11.3.3 Creative Biolabs Virus-like Particle (VLP) Service Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Creative Biolabs Main Business Overview
11.3.5 Creative Biolabs Latest Developments
11.4 Creative Biogene
11.4.1 Creative Biogene Company Information
11.4.2 Creative Biogene Virus-like Particle (VLP) Service Product Offered
11.4.3 Creative Biogene Virus-like Particle (VLP) Service Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Creative Biogene Main Business Overview
11.4.5 Creative Biogene Latest Developments
12 Research Findings and Conclusion
*If Applicable.